European Medicines Agency and Korean Ministry of Food and Drug Safety to share confidential information on treatment, diagnosis, or prevention of COVID-19
The agreement allows them to share confidential information on medicines and complements Agency’s standing confidentiality arrangements with other organisations, aimed at expediting COVID-19 medicine and vaccine development and approval, and avoiding medicine shortages.
Source:
European Medicines Agency